累及肾盂肾盏系统的乳头状肾肿瘤:8225例队列中9例分析
研究回顾8225例机构队列,筛选出9例累及肾盂肾盏系统(PS)的乳头状结构肾肿瘤,其中1例为TFE3重排、1例为FH缺陷型,多数为高级别或具侵袭特征;另发现1例低级别孤立PS受累肿瘤,作者认为现有数据不足以将其分期为pT3a。
要点
- 乳头状结构肾肿瘤累及PS罕见,本队列中仅9例。
- 多数病例为高级别或伴侵袭特征,包括肾门脂肪和区域淋巴结受累。
- 低级别孤立PS受累肿瘤是否应分期为pT3a尚存争议。
核心结论
- 乳头状结构肾肿瘤累及PS是罕见事件。
- 除PRCC外,累及PS的乳头状结构肾肿瘤还可包括其他侵袭性和非侵袭性亚型。
- 现有数据不足以将低级别孤立PS受累的肾源性乳头状肿瘤分期为pT3a(AJCC第8版)。
研究设计与样本
- 回顾性机构队列研究,共8225例。
- 筛选出9例累及PS的乳头状结构肾肿瘤,行组织病理学复习和免疫组化。
- 必要时行TFE3/TFEB荧光原位杂交。
主要发现
- 9例中1例(11%)为TFE3重排,1例(11%)为FH缺陷型RCC。
- 8/9(89%)为WHO/ISUP 3级高级别。
- 6/9(67%)有肾门脂肪受累,5/7(71%)有区域淋巴结受累。
- 1例3.3cm低级别肿瘤孤立累及PS,伴胚系杂合FH p.Lys477dup变异但FH表达保留、S-(2-琥珀半胱氨酸)表达未增高、BRAF V600E免疫组化阳性、染色体微阵列无7/17三体。
关键数值与推荐
- PS受累按AJCC第8版分期为pT3a。
- WHO/ISUP 3级:8/9(89%)。
- 肾门脂肪受累:6/9(67%);区域淋巴结受累:5/7(71%)。
临床怎么用
- 病理诊断乳头状结构肾肿瘤累及PS时需注意鉴别TFE3重排和FH缺陷型等亚型。
- 对低级别孤立PS受累肿瘤,不应仅凭PS受累直接分期为pT3a,需结合更多证据。
局限性
- 样本量小(仅9例)。
- 为单机构回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pelvicalyceal system (PS) involvement by renal cell carcinoma (RCC) is staged as pT3a disease (American Joint Committee on Cancer [AJCC], 8th edition). As papillary RCC (PRCC) has been infrequently represented in studies looking at the prognostic impact of PS involvement, we reviewed our institutional cohort of 8225 cases for PS involvement by PRCC. Nine such cases were subjected to histopathologic review and immunohistochemistry. Fluorescence in situ hybridization for TFE3/TFEB alterations was performed if indicated. One case each (1 of 9, 11%) was classified as TFE3-rearranged and FH-deficient RCC. The majority were high grade (World Health Organization/International Society of Urologic Pathology grade 3: 8 of 9, 89%) or had features of aggressive disease, including hilar fat (6 of 9, 67%) and regional lymph node involvement (5 of 7, 71%). One low-grade 3.3-cm tumor with isolated PS involvement with a germline heterozygous FH p.Lys477dup alteration with retained FH, lack of increased S-(2-succino)-cysteine expression, BRAF V600E immunohistochemistry positivity, and lack of trisomy 7/17 on chromosomal microarray was identified, arguing against an FH-deficient and conventional PRCC. Our study shows that PS involvement by renal neoplasia with papillary architecture is a rare event. Aside from PRCC, it is important to note that these may include other aggressive and nonaggressive subtypes of renal neoplasia with papillary architecture. One case of isolated PS involvement by a low-grade, noninvasive tumor that we refer to as nephrogenic papillary neoplasm was identified. At present, there are insufficient data to stage such tumors as pT3a (AJCC, 8th edition), and additional studies are needed to address this question.
引用
- Gupta S, Cheville JC, Galeano BK, et al. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol. 2020. PMID: 33166576. doi:10.1016/j.humpath.2020.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。